EVIO (EVIO) EPS (Basic): $-0.56 (TTM As of Jun. 2020)


What is EVIO EPS (Basic)?

EVIO EVIO -98.00% EPS (Basic) is $-0.56 as of Jun. 2020.

EVIO's basic earnings per share (Basic EPS) for the three months ended in Jun. 2020 was $-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.56.

EVIO's EPS (Diluted) for the three months ended in Jun. 2020 was $-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was $-0.56.

EVIO's EPS without NRI for the three months ended in Jun. 2020 was $-0.04. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2020 was -0.37.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

EVIO  (OTCPK:EVIO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

EVIO EPS (Basic) Related Terms

EVIO EPS (Basic) Historical Data

* Premium members only.

The historical data trend for EVIO's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO EPS (Basic) Chart

EVIO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19
EPS (Basic)
-0.44 -0.49 -0.37 -0.70 -0.69

EVIO Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.40 -0.07 -0.06 -0.03

EVIO EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

EVIO's Basic EPS for the fiscal year that ended in Sep. 2019 is calculated as

Basic EPS (A: Sep. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-18.549-0)/26.888
=-0.69

EVIO's Basic EPS for the quarter that ended in Jun. 2020 is calculated as

Basic EPS (Q: Jun. 2020 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.349-0)/49.562
=-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.56 mean?
EVIO (EVIO) has a EPS (Basic) of $-0.56 as of Jun. 2020. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on EVIO and its competitors.
Is EVIO's EPS (Basic) too high?
EVIO's current EPS (Basic) is $-0.56.
How does EVIO's EPS (Basic) compare to VCBD and ACCA?
EVIO's EPS (Basic) of $-0.56 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on EVIO and its competitors. EVIO's current EPS (Basic) is $-0.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current EPS (Basic) of $-0.56. The current EPS (Basic) is $-0.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For EVIO (EVIO), the current EPS (Basic) is $-0.56 as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.